nach oben

Erschienen in:

01.06.2010 | Original paper

Diabetes and risk of incident cancer: a large population-based cohort study in Israel

verfasst von: Gabriel Chodick, Anthony D. Heymann, Lena Rosenmann, Manfred S. Green, Shira Flash, Avi Porath, Ehud Kokia, Varda Shalev

Erschienen in: Cancer Causes & Control | Ausgabe 6/2010

Einloggen, um Zugang zu erhalten

Abstract

Type 2 diabetes mellitus has been associated with an increased risk of a variety of cancers in observational studies, but few have reported the relationship between diabetes and cancer risk in men and women separately. The main goal of this retrospective cohort study was to evaluate the sex-specific risk of incident overall and site-specific cancer among people with DM compared with those without, who had no reported history of cancer at the start of the follow-up in January 2000. During an average of 8 years of follow-up (SD = 2.5), we documented 1,639 and 7,945 incident cases of cancer among 16,721 people with DM and 83,874 free of DM, respectively. In women, DM was associated with an adjusted hazard ratio of 1.96 (95% CI: 1.53–2.50) and 1.41 (95% CI: 1.20–1.66) for cancers of genital organs and digestive organs, respectively. A significantly reduced HR was observed for skin cancer (0.38; 95% CI: 0.22–0.66). In men with DM, there was no significant increase in overall risk of cancer. DM was related with a 47% reduction in the risk of prostate cancer. These findings suggest that the nature of the association between DM and cancer depends on sex and specific cancer site.

Roglic G, Unwin N, Bennett P, Mathers C, Tuomilehto J, Nag S et al (2005) The burden of mortality attributable to diabetes: realistic estimates for the year 2000. Diabetes Care 28:2130–2135CrossRefPubMed

World Health Organization (2008) Diabetes programme. Fact sheet no 312 cited. Available from: http://www.who.int/diabetes/facts/world_figures/en/

Stamler J, Vaccaro O, Neaton J, Wentworth D (1993) Diabetes, other risk factors, and 12 years cardiovascular mortality for men screened in the multiple risk factor intervention trial. Diabetes Care 16:434–444CrossRefPubMed

Adami HO, McLaughlin J, Ekbom A, Berne C, Silverman D, Hacker D et al (1996) Cancer risk in patients with diabetes mellitus. J Natl Cancer Inst 88:307–314CrossRef

Shin C, Moon B, Park K, Kim S, Park S, Chung M et al (2001) Serum 8-Hydroxy-Guanine levels are increased in diabetic patients. Diabetes Care 24:733–737CrossRefPubMed

Bach L, Rechler M (1992) Insulin-like growth factors and diabetes. Diabetes Metab Rev 8:229–257CrossRefPubMed

Calle EE, Murphy TK, Rodriguez C, Thun MJ, Heath CW Jr (1998) Diabetes mellitus and pancreatic cancer mortality in a prospective cohort of United States adults. Cancer Causes Control 9(4):403–410CrossRefPubMed

Everhart J, Wright D (1995) Diabetes mellitus as a risk factor for pancreatic cancer. A meta-analysis. JAMA 273(20):1605–1609CrossRefPubMed

Gapstur S, Gann P, Lowe W, Liu K, Colangelo L, Dyer A (2000) Abnormal glucose metabolism and pancreatic cancer mortality. JAMA 283:2552–2558CrossRefPubMed

10.

Silverman DT, Schiffman M, Everhart J, Goldstein A, Lillemoe KD, Swanson GM et al (1999) Diabetes mellitus, other medical conditions and familial history of cancer as risk factors for pancreatic cancer. Br J Cancer 80(11):1830–1837CrossRefPubMed

11.

Smith GD, Egger M, Shipley MJ, Marmot MG (1992) Post-challenge glucose concentration, impaired glucose tolerance, diabetes, and cancer mortality in men. Am J Epidemiol 136(9):1110–1114PubMed

12.

Coughlin SS, Calle EE, Teras LR, Petrelli J, Thun MJ (2004) Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults. Am J Epidemiol 159(12):1160–1167CrossRefPubMed

13.

Hardell L, Fredrikson M, Axelson O (1996) Case-control study on colon cancer regarding previous disease and drug intake. Int J Oncol 8:439–444

14.

Kune G, Kune S, Watson L (1988) Colorectal cancer risk, chronic illnesses, operations, and medications: case-control results from the Melbourne colorectal cancer study. Cancer Res 48:4399–4404PubMed

15.

La Vecchia C, D’Avanzo B, Negri E, Franceschi S (1991) History of selected diseases and the risk of colorectal cancer. Eur J Cancer 27:582–586CrossRefPubMed

16.

La Vecchia C, Negri E, Decarli A, Franceschi S (1997) Diabetes mellitus and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev 6(12):1007–1010PubMed

17.

Will JC, Galuska DA, Vinicor F, Calle EE (1998) Colorectal cancer: another complication of diabetes mellitus? Am J Epidemiol 147(9):816–825PubMed

18.

Adami HO, Chow WH, Nyren O, Berne C, Linet MS, Ekbom A et al (1996) Excess risk of primary liver cancer in patients with diabetes mellitus. J Natl Cancer Inst 88(20):1472–1477CrossRefPubMed

19.

Adami HO, McLaughlin J, Ekbom A, Berne C, Silverman D, Hacker D et al (1991) Cancer risk in patients with diabetes mellitus. Cancer Causes Control 2(5):307–314CrossRefPubMed

20.

La Vecchia C, Negri E, Decarli A, Franceschi S (1997) Diabetes mellitus and the risk of primary liver cancer. Int J Cancer 73(2):204–207CrossRefPubMed

21.

La Vecchia C, Negri E, Franceschi S, D’Avanzo B, Boyle P (1994) A case-control study of diabetes mellitus and cancer risk. Br J Cancer 70(5):950–953PubMed

22.

Goodman M, Cologne J, Moriwaki H, Vaeth M, Mabuchi K (1997) Risk factors for primary breast cancer in Japan: 8 year follow-up of atomic bomb survivors. Prev Med 26:144–153CrossRefPubMed

23.

Moseson M, Koenig K, Shore R, Pasternack B (1993) The influence of medical conditions associated with hormones on the risk of breast cancer. Int J Epidemiol 22:1000–1009CrossRefPubMed

24.

O’Mara BA, Byers T, Schoenfeld E (1985) Diabetes mellitus and cancer risk: a multisite case-control study. Journal of chronic diseases 38(5):435–441CrossRefPubMed

25.

Ragozzino M, Melton L, Chu C, Palumbo P (1982) Subsequent cancer risk in the incidence cohort of Rochester, Minnesota, residents with diabetes mellitus. Journal of chronic diseases 35:13–19CrossRefPubMed

26.

Wideroff L, Gridley G, Mellemkjaer L, Chow WH, Linet M, Keehn S et al (1997) Cancer incidence in a population-based cohort of patients hospitalized with diabetes mellitus in Denmark. J Natl Cancer Inst 89(18):1360–1365CrossRefPubMed

27.

Kreiger N, Marrett L, Dodds L, Hilditch S, Darlington G (1993) Risk factors for renal cell carcinoma: results of a population-based case-control study. Cancer Causes Control 4:101–110CrossRefPubMed

28.

Mellemgaard A, Niwa S, Mehl E, Engholm G, McLaughlin J, Olsen J (1994) Risk factors for renal cell carcinoma in Denmark: role of medication and medical history. Int J Epidemiol 23:923–930CrossRefPubMed

29.

Schlehofer B, Pommer W, Mellemgaard A, Stewart J, McCredie M, Niwa S et al (1996) International renal-cell-cancer study. VI. The role of medical and family history. Int J Cancer 66:723–726CrossRefPubMed

30.

Cerhan J, Wallace R, Folsom A, Potter J, Sellers T, Zheng W et al (1997) Medical history risk factors for non-Hodgkin’s lymphoma in older women. J Natl Cancer Inst 89:314–318PubMed

31.

Shoff SM, Newcomb PA (1998) Diabetes, body size, and risk of endometrial cancer. Am J Epidemiol 148(3):234–240PubMed

32.

Weiderpass E, Persson I, Adami HO, Magnusson C, Lindgren A, Baron JA (2000) Body size in different periods of life, diabetes mellitus, hypertension, and risk of postmenopausal endometrial cancer (Sweden). Cancer Causes Control 11(2):185–192CrossRefPubMed

33.

Adler AI, Weiss NS, Kamb ML, Lyon JL (1996) Is diabetes mellitus a risk factor for ovarian cancer? A case-control study in Utah and Washington (United States). Cancer Causes Control 7(4):475–478CrossRefPubMed

34.

Adami H, McLaughlin J, Ekbom A, Berne C, Silverman D, Hacker D et al (1991) Cancer risk in patients with diabetes mellitus. Cancer Causes Control 2:307–314CrossRefPubMed

35.

Adler A, Weiss N, Kamb M, Lyon J (1996) Is diabetes mellitus a risk factor for ovarian cancer? A case-control study in Utah and Washington (United States). Cancer Causes Control 7:475–478CrossRefPubMed

36.

Coughlin S, Calle E, Teras L, Petrelli J, Thun M (2004) Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults. Am J Epidemiol 159:1160–1167CrossRefPubMed

37.

Giovannucci E, Michaud D (2007) The role of obesity and related metabolic disturbances in cancers of the colon, prostate, and pancreas. Gastroenterology 132:2208–2225CrossRefPubMed

38.

Inoue M, Iwasaki M, Otani T, Sasazuki S, Noda M, Tsugane S (2006) Diabetes mellitus and the risk of cancer: results from a large-scale population-based cohort study in Japan. Arch Intern Med 166:1871–1877CrossRefPubMed

39.

Kuriki K, Hirose K, Tajima K (2007) Diabetes and cancer risk for all and specific sites among Japanese men and women. Eur J Cancer Prev 16:83–89CrossRefPubMed

40.

Nilsen T, Vatten L (2001) Prospective study of colorectal cancer risk and physical activity, diabetes, blood glucose and BMI: exploring the hyperinsulinaemia hypothesis. Br J Cancer 84:417–422CrossRefPubMed

41.

Folsom AR, Anderson KE, Sweeney C, Jacobs DR Jr (2004) Diabetes as a risk factor for death following endometrial cancer. Gynecol Oncol 94(3):740–745CrossRefPubMed

42.

Bendelac J (2009) Membership in sick funds 2008. Israel National Insurance Institute, Jerusalem

43.

Chodick G, Heymann A, Shalev V, Kookia E (2003) The epidemiology of diabetes in a large Israeli HMO. Eur J Epidemiol 18:1143–1146CrossRefPubMed

44.

Heymann A, Chodick G, Halkin H, Karasik A, Shalev V, Shemer J et al (2006) The implementation of managed care for diabetes using medical informatics in a large preferred provider organization. Diabetes Res Clin Pract 71:290–298CrossRefPubMed

45.

American Diabetes Association (2002) Management of dyslipidemia in adults with diabetes. Diabetes Care 25(Suppl. 1):S74–S77

46.

Heymann A, Chodick G, Halkin H, Kokia E, Shalev V (2007) Description of a diabetes disease register extracted from a central database. Harefuah 146:15–79PubMed

47.

Israel Center for Disease Control (1999) Health status in Israel 1999. Tel-Hashomer: Israel ministry of health. Report no.: 209

48.

Israel Central Bureau of Statistics (1998) 1995 Census of population and housing Jerusalem

49.

Cox DR (1972) Regression models and life tables (with discussion). J R Stat Soc B 32:187–220

50.

Larsson S, Orsini N, Wolk A (2005) Diabetes mellitus and risk of colorectal cancer: a meta-analysis. J Natl Cancer Inst 97:1679–1687PubMedCrossRef

51.

Hu F, Manson J, Liu S, Hunter D, Colditz G, Michels K (1999) Prospective study of adult onset diabetes mellitus (type 2) and risk of colorectal cancer in women. J Natl Cancer Inst 91:542–547CrossRefPubMed

52.

Huxley R, Ansary-Moghaddam A, Berrington de González A, Barzi F, Woodward M (2005) Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies. Br J Cancer 92:2076–2083CrossRefPubMed

53.

Le Marchand L, Wilkens L, Kolonel L, Hankin J, Lyu L (1997) Associations of sedentary lifestyle, obesity, smoking, alcohol use, and diabetes with the risk of colorectal cancer. Cancer Res 57:4787–4794PubMed

54.

Limburg P, Anderson K, Johnson T, Jacobs D Jr, Lazovich D, Hong C (2005) Diabetes mellitus and subsite-specific colorectal cancer risks in the Iowa Women’s Health Study. Cancer Epidemiol Biomarkers Prev 14:133–137PubMed

55.

O’Mara B, Byers T, Schoenfeld E (1985) Diabetes mellitus and cancer risk: a multisite case-control study. J Chronic Dis 38:435–441CrossRefPubMed

56.

Wei E, Ma J, Pollak M, Rifai N, Fuchs C, Hankinson S et al (2005) A prospective study of C-Peptide, insulin-like growth Factor-I, insulin-like growth factor binding Protein-1, and the risk of colorectal cancer in women. Cancer Epidemiol Biomarkers Prev 14:850–855CrossRefPubMed

57.

Khaw K, Wareham N, Bingham S, Luben R, Welch A, Day N (2004) Preliminary communication: glycated hemoglobin, diabetes, and incident colorectal cancer in men and women: a prospective analysis from the European prospective investigation into cancer-Norfolk study. Cancer Epidemiol Biomarkers Prev 13:915–919PubMed

58.

Kasper J, Liu Y, Giovannucci E (2009) Diabetes mellitus and risk of prostate cancer in the health professionals follow-up study. Int J Cancer 124:1398–1403CrossRefPubMed

59.

Waters K, Henderson B, Stram D, Wan P (2009) LN. K, Haiman C. Association of Diabetes With Prostate Cancer Risk in the Multiethnic Cohort. Am J Epidemiol. 169:937–945

60.

Weissmann A, Linn S, Weltfriend S, Friedman-Birnbaum R (2000) Epidemiological study of classic Kaposi’s sarcoma: a retrospective review of 125 cases from northern Israel. J Eur Acad Dermatol Venereol 14:91–95CrossRefPubMed

61.

Anderson L, Lauria C, Romano N, Brown E, Whitby D, Graubard B et al (2008) Risk factors for classical Kaposi sarcoma in a population-based case-control study in Sicily. Cancer Epidemiol Biomarkers Prev 17:3435–3443CrossRefPubMed

62.

Scott T, Carroll M, Cogliano F, Smith B, Lamorte W (1999) A case-control assessment of risk factors for gallbladder carcinoma. Dig Dis Sci 44:1619–1625CrossRefPubMed

63.

Strom B, Soloway R, Rios-Dalenz J, Rodriguez-Martinez H, West S, Kinman J et al (1995) Risk factors for gallbladder cancer. An international collaborative case-control study. Cancer 76:1747–1756CrossRefPubMed

64.

Yagyu K, Lin Y, Obata Y, Kikuchi S, Ishibashi T, Kurosawa M et al (2004) Bowel movement frequency, medical history and the risk of gallbladder cancer death: a cohort study in Japan. Cancer Sci 95:674–678CrossRefPubMed

65.

Zatonski W, Lowenfels A, Boyle P, Maisonneuve P, Bueno de Mesquita H, Ghadirian P et al (1997) Epidemiologic aspects of gallbladder cancer: a case-control study of the SEARCH program of the international agency for research on cancer. J Natl Cancer Inst 89:1132–1138CrossRefPubMed

66.

Xue F, Michels K (2007) Diabetes, metabolic syndrome, and breast cancer: a review of the current evidence. Am J Clin Nutr 86:s823–s835PubMed

67.

Iezzoni L (1997) Assessing quality using administrative data. Ann Intern Med 127:666–674PubMed

68.

Szklo M, Javier Nieto F (2007) Epidemiology: beyond the basics Sudbury, mass. Aspen, Gaithersburg, MD

Titel: Diabetes and risk of incident cancer: a large population-based cohort study in Israel
verfasst von: Gabriel Chodick
Anthony D. Heymann
Lena Rosenmann
Manfred S. Green
Shira Flash
Avi Porath
Ehud Kokia
Varda Shalev
Publikationsdatum: 01.06.2010
Verlag: Springer Netherlands
Erschienen in: Cancer Causes & Control / Ausgabe 6/2010
Print ISSN: 0957-5243
Elektronische ISSN: 1573-7225
DOI: https://doi.org/10.1007/s10552-010-9515-8

Neu im Fachgebiet Onkologie

24.04.2024 | DGIM 2024 | Nachrichten

Springer Medizin

Diabetes and risk of incident cancer: a large population-based cohort study in Israel

Abstract

Neu im Fachgebiet Onkologie

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Krebspatienten impfen: Was? Wen? Und wann nicht?

Müde im Alter? Auch an die Nebenniere denken

Update Onkologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 6/2010

Childhood leukaemia and parental occupational exposure to pesticides: a systematic review and meta-analysis

Alcohol and risk of breast cancer in Mexican women

Genetic variation in sex-steroid receptors and synthesizing enzymes and colorectal cancer risk in women

Non-cancer mortality among long-term survivors of adult cancer in Korea: national cancer registry study

Estimation of cancer incidence and mortality attributable to smoking in China

Intra-individual variation in serum C-reactive protein over 4 years: an implication for epidemiologic studies

Neu im Fachgebiet Onkologie

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Krebspatienten impfen: Was? Wen? Und wann nicht?

Müde im Alter? Auch an die Nebenniere denken

Update Onkologie